Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MagNeoSug: Sugammadex vs Neostigmine for Rocuronium Reversal with Magnesium Interaction
NCT03497923Phase 4Completed
- Start
- Feb 2019
- Primary completion
- Apr 2023
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB). Started Feb 2019; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT03497923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497923.